{
    "title": "Novartis wins first FDA approval of biosimilar drug",
    "url": "https://www.dailymail.co.uk/wires/afp/article-2983156/Novartis-wins-FDA-approval-biosimilar-drug.html",
    "date": "2015-03-06",
    "keywords": [
        "drug",
        "approval",
        "march",
        "cancer",
        "fda",
        "product",
        "novartis",
        "gmt",
        "door",
        "biotech",
        "giant",
        "zarxio",
        "safety",
        "care",
        "afp",
        "email",
        "food",
        "administration",
        "unit",
        "government",
        "countrythe",
        "effectiveness",
        "neupogen",
        "blood",
        "chemotherapy",
        "sebastien",
        "bozon",
        "generic",
        "living",
        "organism",
        "evidence",
        "productthe",
        "breakthrough",
        "process",
        "part",
        "president",
        "barack",
        "obamas",
        "healthcare",
        "reformsthe",
        "act",
        "effect",
        "licensure",
        "pathway",
        "access",
        "commissioner",
        "hamburg",
        "health",
        "community",
        "meet",
        "agencys",
        "efficacy",
        "quality",
        "standardsthe",
        "placeholder",
        "substitute",
        "name",
        "filgrastim",
        "time",
        "namedneupogen",
        "amgen",
        "percent",
        "midday",
        "trade",
        "stock",
        "market"
    ],
    "category": [
        "wires",
        "afp"
    ]
}